title: KASL clinical practice guidelines: management of alcoholic liver disease.
mesh_terms: D064829:Alcohol Abstinence / Q000523:psychology; D000428:Alcohol Drinking; D019973:Alcohol-Related Disorders / Q000175:diagnosis; D001418:Baclofen / Q000627:therapeutic use; D004221:Disulfiram / Q000627:therapeutic use; D005235:Fatty Liver, Alcoholic / Q000503:physiopathology; D006519:Hepatitis, Alcoholic / Q000503:physiopathology; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology; D008108:Liver Diseases, Alcoholic / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control*; D009271:Naltrexone / Q000627:therapeutic use; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
chemical_list: D009271:Naltrexone; D001418:Baclofen; D004221:Disulfiram
keywords: Alcoholic liver disease; Practice guidelines